Liposomes as carriers of hydrophilic small molecule drugs: strategies to enhance encapsulation and delivery

JO Eloy, MC de Souza, R Petrilli, JPA Barcellos… - Colloids and surfaces B …, 2014 - Elsevier
Although hydrophilic small molecule drugs are widely used in the clinic, their rapid
clearance, suboptimal biodistribution, low intracellular absorption and toxicity can limit their …

[HTML][HTML] Advances in nanomedical applications: diagnostic, therapeutic, immunization, and vaccine production

A El-Sayed, M Kamel - Environmental Science and Pollution Research, 2020 - Springer
In the last decades, nanotechnology-based tools started to draw the attention of research
worldwide. They offer economic, rapid, effective, and highly specific solutions for most …

Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer

P Juzenas, W Chen, YP Sun, MAN Coelho… - Advanced drug delivery …, 2008 - Elsevier
Semiconductor quantum dots and nanoparticles composed of metals, lipids or polymers
have emerged with promising applications for early detection and therapy of cancer …

PEG-SS-PPS: reduction-sensitive disulfide block copolymer vesicles for intracellular drug delivery

S Cerritelli, D Velluto, JA Hubbell - Biomacromolecules, 2007 - ACS Publications
Under appropriate conditions, block copolymeric macroamphiphiles will self-assemble in
water to form vesicles, referred to as polymersomes. We report here polymersomes that can …

Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation

C Guiducci, G Ott, JH Chan, E Damon… - The Journal of …, 2006 - rupress.org
Human plasmacytoid dendritic cells (PDCs) can produce interferon (IFN)-α and/or mature
and participate in the adaptive immune response. Three classes of CpG oligonucleotide …

Parasitic diseases: liposomes and polymeric nanoparticles versus lipid nanoparticles

AA Date, MD Joshi, VB Patravale - Advanced drug delivery reviews, 2007 - Elsevier
Parasitic diseases such as malaria, leishmaniasis, and trypanosomiasis represent a
significant global burden and pose a great challenge to drug discovery and delivery …

Review on Experimental Treatment Strategies Against Trypanosoma cruzi

AL Mazzeti, P Capelari-Oliveira, MT Bahia… - Journal of …, 2021 - Taylor & Francis
Chagas disease is a neglected tropical disease caused by the protozoan Trypanosoma
cruzi. Currently, only nitroheterocyclic nifurtimox (NFX) and benznidazole (BNZ) are …

Therapeutical approaches under investigation for treatment of Chagas disease

MT Bahia, LF Diniz, VCF Mosqueira - Expert opinion on …, 2014 - Taylor & Francis
Introduction: A century after its discovery, American trypanosomiasis or Chagas disease
remains a serious health problem in Latin America, where it affects around 7–8 million …

Small molecule therapeutic-loaded liposomes as therapeutic carriers: from development to clinical applications

JY Hwang, Z Li, XJ Loh - RSC advances, 2016 - pubs.rsc.org
While small hydrophilic therapeutic molecules have proved to be exceptionally effective in
curing diseases, their in vivo efficacy remains low. Small molecule therapeutics infused in …

Nanomedicines against Chagas disease: an update on therapeutics, prophylaxis and diagnosis

MJ Morilla, EL Romero - Nanomedicine, 2015 - Taylor & Francis
Chagas disease is a neglected parasitic infection caused by the protozoan Trypanosoma
cruzi. After a mostly clinically silent acute phase, the disease becomes a lifelong chronic …